Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 2/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.54 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.54 |
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.46 |
| ▸ | PGR | P06401 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | AHR | P35869 | 2/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23204393 | 0.90 | CYP11B1 (0.47) | CYP11B1CYP11B2CYP17A1HRH3PGR | |
| SCHEMBL21531337 | 0.89 | HRH3 (0.50) | CYP11B1CYP11B2CYP17A1HRH3PGR | |
| SCHEMBL23204740 | 0.84 | HRH3 (0.43) | CYP11B1CYP11B2CYP17A1HRH3PGR | |
| SCHEMBL744467 | 0.84 | CYP2A6 (0.50) | CYP11B1CYP11B2CYP17A1MAOAMAOB | |
| SCHEMBL5477144 | 0.84 | CYP11B1 (0.61) | CYP11B1CYP11B2CYP17A1HRH3PGR | |
| SCHEMBL7343284 | 0.82 | CYP11B1 (0.65) | CYP11B1CYP11B2CYP17A1HRH3PGR | |
| SCHEMBL1773406 | 0.81 | MAOB (0.64) | CYP11B2MAOAMAOBAHRKIF11 | |
| SCHEMBL15496905 | 0.81 | MAOB (0.64) | CYP11B2MAOAMAOBAHRKIF11 | |
| SCHEMBL13098708 | 0.81 | ALDH1A1 (0.52) | CYP11B1CYP11B2MAOB | |
| SCHEMBL22155637 | 0.81 | MAOB (0.44) | CYP11B1CYP11B2HRH3MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021066319-A2 | TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 주식회사 랩토 | 2021-04-08 | — | — | WO | disclosed |
| US-20200203632-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-06-25 | — | — | US | disclosed |
| EP-2311826-B1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEMICAL LTD (KR) | 2017-05-24 | — | — | EP | disclosed |
| US-9139562-B2 | Nitrogen-containing heterocyclic compound and organic electronic device using the same | LG CHEM, LTD. (KR) | 2015-09-22 | — | — | US | disclosed |
| US-9139562-B2 | Nitrogen-containing heterocyclic compound and organic electronic device using the same | LG CHEM, LTD. (KR) | 2015-09-22 | — | — | US | disclosed |
| US-9139562-B2 | Nitrogen-containing heterocyclic compound and organic electronic device using the same | LG CHEM, LTD. (KR) | 2015-09-22 | — | — | US | disclosed |
| CN-102119158-B | Nitrogen-containing heterocyclic compound and organic electronic device using same | LG CHEM, LTD. (KR) | 2015-09-09 | — | — | CN | disclosed |
| CN-103333167-A | Novel nitrogen-containing heterocyclic compound and organic electronic device using the same | LG CHEMICAL LTD | 2013-10-02 | — | — | CN | disclosed |
| EP-2570412-A1 | Novel nitrogen-containing heterocyclic compound and organic electronic device using the same | LG Chem, Ltd. (KR) | 2013-03-20 | — | — | EP | disclosed |
| EP-2570412-A1 | Novel nitrogen-containing heterocyclic compound and organic electronic device using the same | LG Chem, Ltd. (KR) | 2013-03-20 | — | — | EP | disclosed |
| US-8368062-B2 | Nitrogen-containing heterocyclic compound and organic electronic device using the same | LG CHEM, LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| US-8368062-B2 | Nitrogen-containing heterocyclic compound and organic electronic device using the same | LG CHEM, LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| US-20120007069-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2012-01-12 | — | — | US | disclosed |
| US-20120007069-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2012-01-12 | — | — | US | disclosed |
| US-20120007069-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2012-01-12 | — | — | US | disclosed |
| CN-102119158-A | Novel nitrogen-containing heterocyclic compound and organic electronic device using the same | LG CHEMICAL LTD | 2011-07-06 | — | — | CN | disclosed |
| US-20110127513-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2011-06-02 | — | — | US | disclosed |
| US-20110127513-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2011-06-02 | — | — | US | disclosed |
| US-20110127513-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2011-06-02 | — | — | US | disclosed |
| EP-2311826-A2 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG Chem, Ltd. (KR) | 2011-04-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120007069-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | VDAC2, VDAC1, VDAC3 | CYP11B1 1811/4885CYP11B2 1446/4885CYP17A1 3354/4885 |
| US-20110127513-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | VDAC2, VDAC1, VDAC3 | CYP11B1 1811/4885CYP11B2 1446/4885CYP17A1 3354/4885 |
| US-20200203632-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SLCO4C1, EML4, SLCO2A1 | CYP11B1 1279/4885CYP11B2 956/4885CYP17A1 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.